 A federal judge has ruled against a Justice Department antitrust challenge to UnitedHealth Groups 13 billion acquisition of Change Healthcare, a health tech firm, The Wall Street Journal reported Monday Sept. 19. This sees a rejection of the claims that the deal would unlawfully shut down competition and limit innovation. 